News about Diabetes

"We were walking in the streets, chanting 'research for the people, not for profit'"

From emergency surgeon to discoverer of GLP-1 and its effects on insulin production and satiety, CBMR Group Leader Professor Jens Juul Holst has spent fifty years pursuing one question: how does metabolism go wrong, and…

Ancient arctic adaptations may influence modern disease risk

Inuit in Greenland possess a unique genome, which has evolved over thousands of years as they adapted to a cold climate and consumed a diet largely consisting of marine mammals. Now, a team of international scientists…

Manisha Nair: Improving women’s cardiometabolic health in pregnancy

Meet Manisha Nair, a newly appointed Professor of Global Health at the Global Health Section, University of Copenhagen.

Discovery of new ciliary proteins suggests link between cell antennae and chronic diseases

New research findings from the Department of Biology at the University of Copenhagen bring us one step closer to understanding why defects in certain genes can cause kidney disease, obesity and diabetes.

Students tackle chronic disease in conflict zones at Global Health Solutions 2025

The University of Copenhagen’s annual global health case challenge, Global Health Solutions, concluded with a showcase of student-led innovation aimed at addressing chronic disease care in war zones.

Interaction between cardiovascular disease and type 2 diabetes and chronic hepatitis B virus infection

Hepatitis B virus (HBV) infection can lead to cirrhosis and cancer of the liver, and new knowledge suggests that chronic virus infections can promote arteriosclerosis, insulin resistance and increased mortality due to…

Microbiome breakthrough: Gut bacterium may hold key to future treatments for widespread chronic diseases

An international research team led by scientists from the University of Copenhagen has discovered a common gut bacterium that lowers body weight and blood sugar while increasing bone density. The finding could pave the…

From early humanity to treating today’s metabolic diseases

Two researchers from SUND, Associate Professor Frido Welker and Assistant Professor Lærke Smidt Gasbjerg, have received Sapere Aude grants of more than 6 mill DKK each.

From early humanity to treating today’s metabolic diseases

Two researchers from SUND, Associate Professor Frido Welker and Assistant Professor Lærke Smidt Gasbjerg, have received Sapere Aude grants of more than 6 mill DKK each.

Clinical and preclinical research recognised with prestigious awards

The Kirsten and Freddy Johansen Foundation will present its two annual prizes for preclinical and clinical research at the Ceremonial Hall today.

Newly discovered ‘molecular fingerprints’ could transform diabetes treatment and diagnosis

Unprecedented insights into insulin resistance could pave the way for better treatments and earlier detection of type 2 diabetes.

Anan Yaghmur is new Professor at IF

As of 1 April, Anan Yaghmur is Professor of Pharmaceutical Physical Chemistry, Self-Assembly Systems, here at the Department of Pharmacy, where he is a member of the Pharmaceutical Physical and Analytical Chemistry…

Metabolism Day 2025 - Some numbers and many thank yous

As interest in the conference has grown across the University, and beyond, we've sold out the impressive Jerne Auditorium for two straight years! Executive Director Juleen Zierath welcoming participants to Metabolis…

LEAP2: A new hormone with big implications for metabolism?

Often called the hunger hormone, ghrelin tells your brain you are hungry and increases your appetite. Another recently discovered hormone, LEAP2, prevents ghrelin from sending these signals, thereby lowering appetite.

Diabetes and hormone disorder research receives millions in funding

The Danish Diabetes and Endocrine Academy supports new research into diabetes and hormone-related research at SUND.

Many Greenlanders Face 10 Times Higher Risk of Diabetes – Exercise May Be Their Only Solution

A significant portion of the Greenlandic Inuit population carries a genetic variant that increases their risk of type 2 diabetes tenfold. Now, researchers from the University of Copenhagen have discovered that the key t…

Salivary biomarkers as a diagnostic tool in type 2 diabetes

The Deshmukh and Hansen Groups have identified distinct molecular and taxonomic signatures in saliva that are associated with type 2 diabetes (T2D).

New weight loss drug target burns energy and lowers appetite – without the nausea and vomiting

Scientists have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity.

Rethinking body mass index standards: Addressing hidden nutritional risks across populations

Current body mass index cut-offs may underestimate disease risk in certain populations, especially in South-East Asia, where a 'thin-fat' phenotype is prevalent.

Genetic study of insulin-releasing beta-cells presents promise for personalized diabetes treatments

An international team of scientists discover new genes and molecular pathways that influence the ability of beta cells to produce and release insulin.

A simple blood test warns of possible cardiometabolic complications for children with obesity

Scientists have detected lipid biomarkers in children and teenagers with obesity that indicate an increased risk of developing type 2 diabetes as adults.

Cone snail venom may improve treatment for hormonal disorders

Sea snails secrete hormone-like toxins causing extended insulin shock in its prey, new research from the University of Copenhagen concludes. The toxin may be used to improve treatment for hormonal disorders.

New research initiative is to shed light on the role of intestinal bacteria in obesity, diabetes, and cardiovascular diseases

A new research initiative, the Microbiome Health Initiative, will investigate whether there is a causal relationship between intestinal bacteria and conditions such as diabetes and cardiovascular diseases. The Departmen…

Global health crisis: Vietnam shows new ways to treat diabetes

Med øget fokus på uformel omsorg er det muligt at forbedre diabetespatienters liv markant. Det viser forskningsprojektet VALID, der netop har afsluttet sin første fase i Vietnam og kan få betydning andre steder.